Halliday J W, McKeering L V, Powell L W
Cancer Res. 1976 Dec;36(12):4486-90.
A highly sensitive technique for isoferritin detection using 125I-labeled monospecific anti-human liver ferritin antibody for the identification of isoferritins after the analysis of small quantities of ferritin by isoelectric focusing in polyacryl-amide gels was applied to the study of renal, pancreatic, and colonic carcinomas. In all tumors studied, the isoferritin composition differed from that of the corresponding normal tissue; major isoferritins with pl more basic than those of the normal tissues were consistently detected. Composition of purified ferritin from metastases closely resembled the isoferritin composition of the primary tumors. Examination of the serum isoferritin profiles of four patients with cancers did not reveal the presence of any tumor-specific changes in isoferritins. It is suggested that the abnormality in tissue ferritins in the three human cancers studied is the synthesis of major isoferritins in the more basic range, rather than the appearance of tumor-specific isoferritins in the more acidic range.
一种高灵敏度的异铁蛋白检测技术,该技术使用125I标记的单特异性抗人肝铁蛋白抗体,在聚丙烯酰胺凝胶中通过等电聚焦分析少量铁蛋白后鉴定异铁蛋白,已应用于肾癌、胰腺癌和结肠癌的研究。在所有研究的肿瘤中,异铁蛋白组成与相应正常组织不同;始终检测到主要等电点比正常组织更偏碱性的异铁蛋白。来自转移灶的纯化铁蛋白组成与原发性肿瘤的异铁蛋白组成非常相似。对四名癌症患者的血清异铁蛋白谱进行检查,未发现异铁蛋白存在任何肿瘤特异性变化。提示在所研究的三种人类癌症中,组织铁蛋白的异常是在更偏碱性范围内主要异铁蛋白的合成,而非在更偏酸性范围内出现肿瘤特异性异铁蛋白。